Finally, the result is that the downregulation of NOX4 inhibits GABAA-γ2 and NMDAR expression in the SDH to alleviate bone cancer pain, compensating for the contribution of NOX4 to central sensitization [23, 164]. The gene discussed is NOX4; the disease is bone neoplasm.